Related Experiment Video

Updated: Jul 7, 2026

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
10:42

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Published on: July 6, 2022

Recent advances in esophageal cancer gene therapy

Hideaki Shimada1, Kazuyuki Matsushita, Masatoshi Tagawa

  • 1Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
|February 23, 2008
PubMed

Insights

Gene therapy offers new hope for esophageal cancer, targeting p53 alterations and angiogenesis. A phase I/II study of adenoviral-mediated p53 gene therapy showed promising clinical results for unresectable cases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Esophageal cancer presents significant treatment challenges.
  • Gene therapy is an emerging strategy for managing malignant diseases.
  • Understanding p53 alterations and angiogenesis is crucial for esophageal cancer treatment.

Purpose of the Study:

  • To review p53 genetic alterations and angiogenesis in esophageal cancer.
  • To present clinical results from a phase I/II study of adenoviral-mediated p53 gene therapy.
  • To discuss experimental therapeutic models for esophageal cancer.

Main Methods:

  • Review of scientific literature on p53 and angiogenesis in esophageal cancer.
  • Analysis of clinical data from a phase I/II adenoviral-mediated p53 gene therapy trial.
  • Evaluation of experimental therapeutic models.

Main Results:

  • Adenoviral-mediated p53 gene therapy demonstrated clinical activity in patients with unresectable esophageal cancer.
  • Review highlights the role of p53 genetic alterations and angiogenesis in esophageal cancer.
  • Experimental models provide insights into potential future therapeutic strategies.

Conclusions:

  • Gene therapy, particularly targeting p53, holds promise for esophageal cancer treatment.
  • Further research into molecular therapies and experimental models is warranted.
  • Clinical trials of gene therapy for esophageal cancer are progressing.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...